Document is current
Any future updates will be listed below
-
Authors
Wang, Chaoyu https://orcid.org/0000-0001-9224-5061
Zhang, Ruoshi
He, Jia
Yu, Lvshan
Li, Xinyan
Zhang, Junxia
Li, Sai https://orcid.org/0000-0002-9353-0355
Zhang, Conggang https://orcid.org/0000-0003-0282-1921
Kagan, Jonathan C. https://orcid.org/0000-0003-2364-2746
Karp, Jeffrey M. https://orcid.org/0000-0002-4752-7374
Kuai, Rui https://orcid.org/0000-0003-2324-1272
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82173751)
- License Information
-
More Information
Article History
Received: 27 April 2022
Accepted: 20 June 2023
First Online: 30 June 2023
Competing interests
: A patent application (202210306460.1) has been filed based on the ultrasound responsive chemotherapeutics for STING activation, with R.K., C.W., R.Z., and J.H. as inventors. J.M.K. and R.K. hold equity and consult for Corner Therapeutics, a company that has licensed IP generated by J.M.K. and R.K. that may benefit financially if the IP is further validated. J.M.K. has been a paid consultant and or equity holder for multiple biotechnology companies (listed here ). The interests of JMK were reviewed and are subject to a management plan overseen by his institutions in accordance with its conflict of interest policies. The remaining authors declare no competing interests.
